Agree, Alkermes didnt want to move it themselves. The bigger question is whether this is just a pawn in the Biogen portfolio and a $1 billion deal is to be had for 273 for MS or not. (wonder if Biogen wanted to annouce Alkermes first so that they wouldn't want more $$ if they saw a big deal with AVXL.
C'mon Chris Miss...get that early Christmas present to shareholders...get the deal done. Stick it to shorty.